Dr. Susan Adams Marik, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 305 W Porphyry St Ste 200, Butte, MT 59701 Phone: 406-496-3627 Fax: 406-723-2496 |
Robert Michael St. John, MD Obstetrics & Gynecology - Obstetrics Medicare: Not Enrolled in Medicare Practice Location: 2500 Continental Drive, Montana Chemical Dependency Center, Butte, MT 59701 Phone: 406-496-5400 Fax: 406-496-5437 |
Dr. James Douglas Bozeman, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 305 W Porphyry St, Suite 200, Butte, MT 59701 Phone: 406-496-3627 Fax: 406-723-2495 |
News Archive
ULURU Inc. (NYSE Alternext: ULU) announced today the presentation of results from the first completed randomized clinical trial for Altrazeal at the SAWC Fall symposium in Washington D.C. September 16-18. The recently completed clinical study compared healing, pain and comfort of skin graft donor sites treated with either Altrazeal(TM) or with a leading commercial sodium carboxymethylcellulose-silver ("CMC-Ag") dressing.
The study entitled "Long term extension of a randomized controlled trial of probiotics using electronic health records" led by researchers in the Swansea University Medical School and the College of Human and Health Sciences, was published in Scientific Reports.
Smart for Life cookies will be the focus of a study in the oncology unit of the Jewish General Hospital, acknowledged as a world leader in many fields of investigation and a key teaching site for McGill University.
"The benefits of this diet are very well known, but the mechanism is not well understood. We believe this is the first time it has been reported that the potential mechanism goes through the inflammation process," said Demosthenes B. Panagiotakos, MSc, PhD with Harokopio University in Athens, Greece.
Merck & Co., Inc. today said a federal court jury in New York found in its favor in the Graves v. Merck case, rejecting the claims of a Florida woman who blamed her dental and jaw related problems on her FOSAMAX use. With today's verdict, Merck has won three of the first four bellwether cases in the FOSAMAX litigation.
› Verified 2 days ago